HKU Scholars Hub: Browsing DSpace

Browsing by Author Thanawala, V

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 4 of 4

	Title	Author(s)	Issue Date	Views
	Longer treatment duration of monthly VIR-2218 results in deeper and more sustained reductions in hepatitis B surface antigen in participants with chronic hepatitis B infection. Oral Presentation (OS090) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Lim, YS Yuen, RMF Cloutier, D Thanawala, V Shen, L Gupta, SV Arizpe, A Cathcart, A Hwang, C Gane, EJ	2022
	Preliminary on-treatment data from a phase 2 study evaluating VIR-2218 in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection Proceeding/Conference:Journal of Hepatology	Yuen, RMF Lim, YS Cloutier, D Shen, L Arizpe, A Pang, P Tay, C Thanawala, V Gupta, SV Cathcart, A Gane, E	2021
	Preliminary results from a phase 2 study evaluating VIR-2218 alone and in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection Proceeding/Conference:APASL 2022, Seoul, Korea, 30 Mar - 3 Apr 2022. Hepatology International	Yuen, RMF Lim, Y-S Cloutier, D Thanawala, V Shen, L Arizpe, A Tay, C Gupta, SV Cathcart, AL Hwang, C Gane, E	2022
	Preliminary results from a phase 2 study evaluating vir-2218 alone and in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection Proceeding/Conference:Oral Presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Yuen, RMF Lim, Y-S Cloutier, D Thanawala, V Shen, L Arizpe, A Tay, C Gupta, SV Cathcart, AL Hwang, C Pang, PS Gane, EJ	2021

Showing results 1 to 4 of 4